Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Hitting the finish line
November 2019
SHARING OPTIONS:

HEIDELBERG, Germany—BioMed X has completed its first research collaboration project with Roche Diagnostics in nanomaterial-based biosensors for near patient testing, the company announced recently. Specifically, BioMed X achieved proof of principle for a sensor platform that will enable the analysis of a variety of analytes from whole human blood samples with a single device. The company's team was able to use this platform to demonstrate the first highly sensitive label-free detection of thyroid-stimulating hormone in undiluted human serum on a new FET sensor design based on gold and graphene. The project was launched in 2015, and an international team worked to design a “field effect transistor-based multimodal sensing platform … with a single-use disposable material for point-of-care diagnostics,” per a BioMed X press release. IP and know-how for this new platform has been transferred to Roche Diagnostics for further development.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.